Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

BCDA | BioCardia Inc.

Index	-	P/E	-	EPS (ttm)	-0.68	Insider Own	44.54%	Shs Outstand	20.08M	Perf Week	5.89%
Market Cap	9.29M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	0.07%	Shs Float	11.99M	Perf Month	-47.44%
Income	-13.01M	PEG	-	EPS next Q	-0.14	Inst Own	15.28%	Short Float / Ratio	1.05% / 0.93	Perf Quarter	-83.90%
Sales	0.42M	P/S	22.13	EPS this Y	7.96%	Inst Trans	-14.69%	Short Interest	0.13M	Perf Half Y	-77.84%
Book/sh	0.08	P/B	5.68	EPS next Y	2.16%	ROA	-147.38%	Target Price	7.50	Perf Year	-78.72%
Cash/sh	0.20	P/C	2.16	EPS next 5Y	-	ROE	-310.91%	52W Range	0.36 - 2.92	Perf YTD	-79.43%
Dividend	-	P/FCF	-	EPS past 5Y	25.25%	ROI	-469.17%	52W High	-85.28%	Beta	1.27
Dividend %	-	Quick Ratio	1.29	Sales past 5Y	119.54%	Gross Margin	5.18%	52W Low	19.38%	ATR	0.05
Employees	36	Current Ratio	1.29	Sales Q/Q	-95.59%	Oper. Margin	-3068.24%	RSI (14)	26.15	Volatility	4.54% 9.13%
Optionable	Yes	Debt/Eq	0.90	EPS Q/Q	-18.73%	Profit Margin	-3061.18%	Rel Volume	0.17	Prev Close	0.43
Shortable	Yes	LT Debt/Eq	0.70	Earnings	Aug 09 AMC	Payout	-	Avg Volume	135.27K	Price	0.43
Recom	2.33	SMA20	-7.61%	SMA50	-44.87%	SMA200	-76.09%	Volume	23,671	Change	0.44%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-21	Downgrade	Dawson James	Buy → Neutral

Sep-06-23 10:31AM	BioCardia (BCDA) Dips 26% on Flunking Heart Failure Study (Zacks) -12.59%
07:15AM	BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs (GlobeNewswire)
Sep-05-23 07:15AM	BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial (GlobeNewswire) -25.54%
Aug-11-23 09:29AM	BioCardia, Inc. (NASDAQ:BCDA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-09-23 06:05PM	BioCardia, Inc. (BCDA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +6.28%
04:05PM	Loading…
04:05PM	BioCardia Reports Second Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
Aug-02-23 07:00AM	BioCardia to Host Q2 2023 Financial Results and Corporate Update Conference Call on August 9, 2023 (GlobeNewswire)
Jul-24-23 07:00AM	BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected (GlobeNewswire) -44.70%
Jul-10-23 08:11AM	Those who invested in BioCardia (NASDAQ:BCDA) a year ago are up 86% (Simply Wall St.)
Jul-05-23 07:00AM	BioCardia Completes Submission of CardiAMP Cell Therapy System in Heart Failure to Japans Pharmaceutical Medical Device Agency (GlobeNewswire)
Jun-20-23 05:14PM	BioCardia Announces FDA Completes Review of Proposed Adaptive Statistical Analysis Design for Ongoing CardiAMP Cell Therapy in Heart Failure Pivotal Study (GlobeNewswire) +6.41%
Jun-08-23 07:00AM	BioCardia Announces Helix Biotherapeutic Delivery Patent Issuance in Japan (GlobeNewswire) +6.53%
May-28-23 08:08AM	Joseph Daly Spends US$177k Buying BioCardia Shares \ (Simply Wall St.)
May-23-23 07:00AM	BioCardia Announces Timing of the Next Data Safety Monitoring Board Meeting for the CardiAMP Cell Therapy in Heart Failure Pivotal Study (GlobeNewswire)
May-12-23 06:06AM	BioCardia First Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
05:45PM	Loading…
May-10-23 05:45PM	BioCardia, Inc. (BCDA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	BioCardia Reports First Quarter 2023 Business Highlights and Financial Results (GlobeNewswire)
May-09-23 07:00AM	BioCardia Announces US Patent on Bone Marrow Derived Neurokinin-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells for Therapeutic Applications (GlobeNewswire)
May-03-23 08:00PM	BioCardia to Host Q1 2023 Financial Results and Corporate Update Conference Call on May 10, 2023 (GlobeNewswire)
Apr-28-23 07:00AM	BioCardia Presentations at Next Generation Cardiovascular Drug Development Summit Now Available (GlobeNewswire)
Apr-04-23 07:00AM	BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies (GlobeNewswire)
Apr-01-23 12:47PM	BioCardia, Inc. (NASDAQ:BCDA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-31-23 06:05AM	We're Keeping An Eye On BioCardia's (NASDAQ:BCDA) Cash Burn Rate (Simply Wall St.)
Mar-29-23 08:15AM	BioCardia Reports Fourth Quarter and Full Year 2022 Business Highlights and Financial Results (GlobeNewswire)
Mar-16-23 07:00AM	BioCardia to Host 2022 Financial Results and Corporate Update Conference Call on March 29, 2023 (GlobeNewswire)
Mar-06-23 01:06PM	BioCardia Outlines Detailed Cell Therapy Data From Heart Failure Study (Benzinga)
07:00AM	Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting (GlobeNewswire)
Feb-01-23 06:30AM	BioCardia and CellProthera Enhance Collaboration for Development of ProtheraCytes for the Treatment of Acute Myocardial Infarction in Europe and Potential Early Access for Patients (GlobeNewswire) -7.48%
Jan-31-23 05:39AM	Shareholders in BioCardia (NASDAQ:BCDA) are in the red if they invested five years ago (Simply Wall St.)
Dec-22-22 07:00AM	BioCardia Letter to Shareholders (GlobeNewswire)
05:07AM	Loading…
Dec-21-22 05:07AM	Insider Buying: The BioCardia, Inc. (NASDAQ:BCDA) Independent Director Just Bought 14% More Shares (Simply Wall St.) +6.55%
Dec-15-22 07:00AM	BioCardia Announces $3.6 Million Private Placement of Common Stock (GlobeNewswire)
Dec-06-22 07:00AM	BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure (Business Wire)
Nov-09-22 05:35PM	BioCardia, Inc. (BCDA) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	BioCardia Reports Third Quarter 2022 Business Highlights and Financial Results (GlobeNewswire)
12:00PM	BioCardia, Inc. (BCDA) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-02-22 05:31PM	BioCardia to Host Q3 2022 Financial Results and Corporate Update Conference Call on November 9, 2022 (GlobeNewswire)
Oct-03-22 01:33PM	BioCardia's Heart Failure Cell Therapy Shows 100% Survival At Two Years (Benzinga) +5.67%
07:00AM	BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting (GlobeNewswire)
Sep-14-22 07:00AM	CardiAMP Cell Therapy Heart Failure Trial Two Year Roll-In Cohort Data to be Presented at Heart Failure Society of America Annual Meeting (GlobeNewswire)
Sep-09-22 07:00AM	BioCardia Announces Participation at H.C. Wainwright Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE) (GlobeNewswire)
Sep-08-22 07:00AM	BioCardia to Participate in Cantor Fitzgeralds Cell and Genetic Medicines Conference (GlobeNewswire)
Sep-06-22 11:03AM	Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation (Simply Wall St.) -5.26%
Aug-31-22 07:00AM	BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial (GlobeNewswire)
Aug-24-22 09:40AM	Has BioCardia (BCDA) Outpaced Other Medical Stocks This Year? (Zacks)
07:00AM	BioCardia Enters Agreement with BlueRock Therapeutics to Provide Enabling Catheter Biotherapeutic Delivery Product Candidates for BlueRocks Cell Therapy to Treat Heart Failure (GlobeNewswire)
Aug-10-22 05:15PM	BioCardia, Inc. (BCDA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:30PM	Edited Transcript of BCDA.OQ earnings conference call or presentation 10-Aug-22 8:30pm GMT (Thomson Reuters StreetEvents)
04:05PM	BioCardia Reports Second Quarter 2022 Business Highlights And Financial Results (GlobeNewswire)
Aug-04-22 02:04PM	BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022 (GlobeNewswire) +5.88%
Aug-01-22 08:00AM	BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial (GlobeNewswire)
Jul-12-22 08:15AM	BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia (GlobeNewswire)
Jun-15-22 08:00AM	BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies (GlobeNewswire)
May-11-22 05:55PM	BioCardia, Inc. (BCDA) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -11.94%
04:15PM	BioCardia Reports First Quarter 2022 Business Highlights and Financial Results (GlobeNewswire)
May-06-22 03:15PM	Follow the Insiders and Buy the Dip in These 3 Stocks (InvestorPlace)
May-04-22 08:30AM	BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022 (GlobeNewswire)
Apr-13-22 10:25AM	BioCardia (BCDA) Gains FDA Nod for ARDS Cell Therapy Study (Zacks) -13.07%
Apr-12-22 07:15AM	BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19 (GlobeNewswire) -7.44%
Mar-30-22 03:51PM	Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation (Simply Wall St.)
Mar-29-22 04:05PM	BioCardia Reports 2021 Financial Results and Recent Business Highlights (GlobeNewswire)
Mar-24-22 08:00AM	BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022 (GlobeNewswire)
Mar-22-22 08:30AM	BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure (GlobeNewswire)
Mar-01-22 08:00AM	BioCardia Receives No Objection Letter from Health Canada, Enabling Company to Expand CardiAMP Cell Therapy Heart Failure Trial into Canada (GlobeNewswire) +5.80%
Feb-14-22 07:30AM	BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed (GlobeNewswire) -12.30%
Feb-03-22 02:53PM	Why Are BioCardia Shares Trading Higher Today? (Benzinga) +27.39%
08:00AM	BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure (Business Wire)
Jan-10-22 08:00AM	BioCardia Announces Participation at the Upcoming Digital Medicine & Medtech Showcase and the H.C. Wainwright BioConnect Virtual Conference (GlobeNewswire)
Dec-15-21 08:00AM	BioCardia Establishes New Manufacturing Facility to Enable Its Cell Therapy Product Candidates (GlobeNewswire)
Nov-10-21 04:30PM	BioCardia Reports Third Quarter 2021 Financial Results and Business Highlights (GlobeNewswire)
Nov-08-21 04:30PM	BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021 (GlobeNewswire)
Nov-02-21 03:02PM	Will BioCardia, Inc. (BCDA) Report Negative Q3 Earnings? What You Should Know (Zacks)
Oct-21-21 07:30AM	BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia (GlobeNewswire)
Oct-12-21 08:00AM	BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies (GlobeNewswire)
Oct-07-21 08:00AM	BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial (GlobeNewswire) +6.45%
Oct-06-21 08:00AM	BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference) (GlobeNewswire)
Sep-28-21 06:46AM	Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation (Simply Wall St.)
Sep-10-21 08:00AM	CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021 (GlobeNewswire)
Sep-09-21 04:32PM	BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference) (GlobeNewswire)
Aug-16-21 08:30AM	Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021 (ACCESSWIRE)
Aug-13-21 08:00AM	BioCardia to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-12-21 10:05AM	BioCardia, Inc. (BCDA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights (GlobeNewswire)
Aug-05-21 03:00PM	Will BioCardia, Inc. (BCDA) Report Negative Q2 Earnings? What You Should Know (Zacks)
Jul-15-21 08:00AM	BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies (GlobeNewswire)
Jun-23-21 08:00AM	BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed (GlobeNewswire) -5.35%
Jun-22-21 08:00AM	BioCardia to Present CardiAMP Cell Therapy Clinical Trial Data at European Society of Cardiology Heart Failure 2021 (GlobeNewswire)
Jun-21-21 08:00AM	BioCardia Announces European Patent Office Decision to Grant Patent on Autologous Cell Therapy Patient Selection Diagnostic Assay (GlobeNewswire)
Jun-18-21 10:48AM	Is BioCardia, Inc. (BCDA) A Good Stock To Buy? (Insider Monkey)
Jun-14-21 08:00AM	BioCardia to Be Added to the Russell Microcap® Index (GlobeNewswire)
Jun-02-21 08:00AM	BioCardia to Present at the LD Micro Virtual Invitational Conference on June 8, 2021 (GlobeNewswire)
May-13-21 12:11PM	BioCardia, Inc. (BCDA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:00AM	BioCardia Reports First Quarter 2021 Financial Results and Business Highlights (GlobeNewswire)
Apr-26-21 08:00AM	BioCardia Signs Agreement with Leading Japanese Biotechnology Company for Catheter Biotherapeutic Delivery Product Candidates (GlobeNewswire)
Apr-01-21 01:52AM	Have Insiders Been Buying BioCardia, Inc. (NASDAQ:BCDA) Shares? (Simply Wall St.)
Mar-30-21 09:15AM	BioCardia, Inc. (BCDA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
08:00AM	BioCardia Reports 2020 Financial Results and Recent Business Highlights (GlobeNewswire)
Mar-15-21 08:00AM	BioCardia to Present at Maxim Groups Inaugural Emerging Growth Virtual Conference (GlobeNewswire)
Feb-23-21 08:00AM	BioCardia Signs Agreement With Leading Japanese Pharmaceutical Company for Catheter Biotherapeutic Delivery Product Candidates (GlobeNewswire)
Feb-17-21 08:30AM	BioCardia Announces Clinical Leadership Changes (GlobeNewswire)

BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Altman Peter	President and CEO	May 26	Buy	1.60	6,200	9,920	469,239	May 30 05:01 PM
FROST PHILLIP MD ET AL	10% Owner	Dec 16	Buy	1.68	595,238	1,000,000	2,025,827	Dec 20 08:15 PM
Altman Peter	President and CEO	Nov 11	Buy	1.86	1,400	2,604	332,947	Nov 14 04:00 PM
Altman Peter	President and CEO	Nov 10	Buy	1.87	3,100	5,797	331,547	Nov 14 04:00 PM
McClung David	Chief Financial Officer	Oct 10	Buy	2.07	2,000	4,140	78,518	Oct 11 07:01 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BCDA | BioCardia Inc.

Upgrade your FINVIZ experience